Very good point. Many including myself most of the time, only think about the share price and how that will help ourselves.....but the real winners of this molecule are those who suffer with something that can be helped. My grandmother had MS and wasn't supposed to see 50 years old. Thankfully her MS went into remission and she passed last year at age 96.

Generally progress/approval doesn't happen as fast as us investors would like or many other's who actually need it unfortunately.

I know 2019 is going to be an exciting year for CYDY with the current indications they are working, but I can see 2020 and out years being exciting also as these other indications develop and trials begin.